AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Validea Joseph Piotroski Strategy Daily Upgrade Report - 7/11/2025
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and t...
- July 11, 2025 02:12 AM PDT
- EODHD
China’s Iranian oil imports near record highs as traders circumvent sanctions
China’s import of Iranian crude oil continued to rise last month as shipments were close to the record highs touched in March, Vortexa said. In June, China’s seaborne crude imports increased by 11% month-over-month and 6% year-over-year, reaching 10.6 million barrels per day, data from the shiptracking agency showed.  This rise occurred despite ongoing maintenance […]
- July 11, 2025 02:01 AM PDT
- Invezz
Boeing Stock Falls. Investors Will Soon Know More About Air India Crash.
Details of a preliminary accident report has been submitted to officials, according to the Times of India. It could be released on Friday. Continue Reading View comments
- July 11, 2025 01:55 AM PDT
- EODHD
Tata Elxsi and Synopsys Collaborate to Accelerate Software-Defined Vehicle Development through Advanced ECU Virtualization Capabilities
Integrated capabilities aim to simplify and speed software development and testing to help reduce related costs and de-risk production timelines BENGALURU, India, July 11, 2025 /PRNewswire/ -- Tata El...
- July 11, 2025 01:39 AM PDT
- EODHD
Glenmark Pharma hits record high after $2B licensing deal for cancer drug
Shares of Glenmark Pharmaceuticals surged 14% to an all-time high on Friday after its biotechnology unit, Ichnos Glenmark Innovation (IGI), signed a landmark licensing deal with US drugmaker AbbVie for its experimental blood cancer drug, ISB 2001. The agreement, announced late Thursday, marks one of the largest biotechnology licensing deals by an Indian company to […]
- July 11, 2025 01:37 AM PDT
- Invezz
Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong
Company Logo Functional dyspepsia, marked by untraceable upper abdominal discomfort, is seeing innovation through pharmacological treatments, lifestyle changes, and alternative therapies like herbal a...
- July 11, 2025 01:21 AM PDT
- EODHD
IEA boosts 2025 oil supply forecast after latest OPEC+ hike
VIENNA (Reuters) -The International Energy Agency on Friday raised its forecast for supply growth this year after OPEC+’s latest decision to pump more oil, while it trimmed its outlook for demand, say...
- July 11, 2025 01:16 AM PDT
- EODHD
Copper's positive, long-term trajectory unchanged despite US tariff, Barrick CEO says
By Chris Mfula LUSAKA (Reuters) -Copper miners remain bullish on the metal’s future prospects even as a looming 50% U.S. tariff creates short-term price volatility, Barrick Mining Corp CEO Mark Bristo...
- July 11, 2025 01:01 AM PDT
- EODHD
Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma
Company Logo Psoriatic arthritis is a chronic inflammatory disease linked to psoriasis, characterized by joint inflammation, pain, and swelling. Affecting both men and women, typically between ages 30...
- July 11, 2025 01:01 AM PDT
- EODHD
Big Tech Needs a Way Out of Its AI Cost Spiral. These 2 Stocks Could Benefit.
Amazon, Google, Microsoft and Meta hope custom chips can slow their pace of AI spending. Enter chip designers Broadcom and Marvell Technology. Continue Reading
- July 11, 2025 12:30 AM PDT
- EODHD